Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00998595 · ClinicalTrials.gov registry record · NA

Gestational Diabetes Follow Up Study

A NA study, sponsored by University of Southern California.

Completed
Registry status
NA
Development phase
216
Enrollment target

NCT00998595: Completed NA study, sponsored by University of Southern California.

NCT00998595 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 216 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00998595, a NA study, has completed, sponsored by University of Southern California.

COMPLETED
Registry status
NA
Development phase
216 participants
Enrollment target

Study Summary

The primary hypothesis underlying this proposal is that the introduction of a Promotora to provide education and proactive follow-up to women with GDM will increase compliance with postpartum glucose tolerance testing. The secondary hypothesis is that the Promotora will improve participation in referral visits for diabetes or preventive care. We will develop the promotora program and begin pilot implementation.

Interventions

  • OTHER Promotora

Trial Details

FieldValue
Enrollment Target 216 participants
Start Date 2009-06
Est. Completion 2011-10
Phase NA
University of Southern California

617 total trials

What the finished NCT00998595 record still lists

NCT00998595 is an interventional study that assigns participants to a tested intervention. The registered 216 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 1 intervention - of which Promotora is the first listed.

NCT00998595 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00998595 about?

NCT00998595 is a clinical study titled "Gestational Diabetes Follow Up Study". The primary hypothesis underlying this proposal is that the introduction of a Promotora to provide education and proactive follow-up to women with GDM will increase compliance with postpartum glucose tolerance testing. The secondary hypothesis is that the Promotora will improve participation in refe...

What is the current status of trial NCT00998595?

This trial is currently completed. It is a NA study. The enrollment target is 216 participants. The study started on 2009-06. Estimated completion is 2011-10.

What interventions are being tested in trial NCT00998595?

The interventions under investigation include: Promotora (OTHER).

Who is sponsoring clinical trial NCT00998595?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00998595's enrollment target sits among peer trials

216 485th of 2000 higher than 1,514 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02609685 · 216 participants · NA

    Active Surveillance of Papillary Thyroid Microcarcinoma

  • NCT04994873 · 216 participants · NA

    Skills to Enhance Positivity in Suicidal Youth

  • NCT05264779 · 216 participants · NA

    The Periviable GOALS Decision Support Tool

  • NCT05434130 · 216 participants · Phase 2

    Modulating Exercise Dosage to Improve Concussion Recovery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00998595, the US trial registry maintained by the National Library of Medicine. NCT00998595 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.